Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors
Clinical trial NCT04830501 · COMPLETED
Trial details
- NCT number
- NCT04830501
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-12
- Primary completion
- 2023-10-18
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.